RxDoctor Payments Data

Marc Singer, MD

Colon & Rectal Surgery · Chicago, ILNPI 1194732909

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (59.8%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 25 manufacturers reported payments, led by Medical Device Business Services, Inc. at 48.8% of the total. Reporting peaked in 2019 at $61,623 and has fallen 98.5% since, to $932 in 2025. Among colon & rectal surgery clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$200,510in general payments, 2019–2025

Across 247 payments — averaging $811.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$98K
  • Olympus Corporation$26K
  • Merck$24K
  • Intuitive Surgical$17K
  • Takeda Pharmaceuticals U.S.A., Inc.$12K
  • Pacira Pharmaceuticals Incorporated$8K
  • plus $16K from 19 others

What the payments were for

  • Consulting fees$119,85160%
  • Speaking & faculty fees$37,72319%
  • Travel & lodging$24,18112%
  • Food & beverage$7,9704%
  • Education$10,7855%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$200,510 in reported general payments places this provider in the 95th percentile of 79 colon & rectal surgery providers in Illinois.

See all colon & rectal surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$90,292
Medicare patients
222
Services billed
486

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates54$3,684
Sodium Chloride0.9 % Sodium Chloride15$813
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl18$263
Neomycin Sulfate37$190
Metronidazole38$55

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →